Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
Prostate Cancer and Prostatic Diseases, Published online: 17 July 2019; doi:10.1038/s41391-019-0162-1Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
No abstract available
Date: Thursday, 03 05, 2020; Speaker: Dr. Randy Jones, University of Virginia School of Nursing; Building: Building 10 (Clinical Center); Lipsett Amphitheater; Videocast Event
For men in VA health system, blacks do not present with more advanced disease or have higher mortality
Ground zero workers had higher rates of cancer, especially prostate and thyroid cancers and leukemia.
Disparities in medical care may account for why African-American men with prostate cancer are almost twice as likely to die as white men with the disease.
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results announced this week show safety and efficacy when the vaccine is used in combination with standard-of-care chemotherapy for patients with inoperable pleural mesothelioma. Targovax, a Scandinavian pharmaceutical company developing the drug, is moving forward with another study combining ONCOS-102 with a checkpoint inhibitor drug such as Keytruda (pembrolizumab) or Opdivo (nivolumab), along with chemotherapy. “We have seen enough data at this point to be going ...
MONDAY, Jan. 27, 2020 -- For men diagnosed with prostate cancer in the Veterans Affairs health system, African-Americans (AAs) do not present with more advanced disease or have worse outcomes compared with non-Hispanic whites (NHWs), according to a...
Beyond simply being discontent about the high cost of health care in the nation, consumers remain in the dark over what that cost may be – even for a standard treatment for prostate cancer, according to a study out of UNC-Chapel Hill.
(Wiley) Among men with prostate cancer who received care from the Veterans Affairs (VA) Health System, an equal-access health care system, African-American men did not have more advanced disease at the time of diagnosis or die earlier than white men, unlike trends seen in the greater US population of patients with prostate cancer. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
(Vanderbilt University Medical Center) A five-year follow-up study of more than 2,000 US men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.